Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment
We, the researchers, propose to link a clinical pharmacist with an internal medicine or family medicine team to provide pharmaceutical care to all patients assigned to the team. The hypothesis is that through this team based approach, pharmacists will act as a resource for providing pharmacotherapeutic advice during the drug therapy decision making process and promote optimal drug use by identifying and resolving actual and potential drug related problems. This study is designed to test this hypothesis, by assessing the impact of this intervention on evidence based, quality of drug therapy indicators, for patients admitted with heart failure (HF), chronic obstructive pulmonary disease (COPD), community acquired pneumonia (CAP), type 2 diabetes mellitus (T2DM), and stable coronary artery disease (CAD).
Heart Failure, Congestive
Pulmonary Disease, Chronic Obstructive
Diabetes Mellitus, Type 2
Behavioral: Integration of a team based clinical pharmacist
Drug: Optimizing therapeutic treatments
Behavioral: Optimizing processes of care
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
|Official Title:||Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment (COLLABORATE)|
- Improvement in proportion of quality indicators achieved, for target diseases as a most responsible or primary diagnosis, between groups. [ Time Frame: in hospital ] [ Designated as safety issue: No ]
- Differences in condition-specific achievement of drug therapy quality indicators; [ Time Frame: in hospital ] [ Designated as safety issue: No ]
- Differences in 6 month hospital readmission rate; [ Time Frame: 6 months ] [ Designated as safety issue: No ]
- Differences in number, type, acceptance rate, and expected impact of all pharmacist interventions; [ Time Frame: in hospital ] [ Designated as safety issue: No ]
- Qualitative evaluation of the impact of the intervention via interviews with the participating pharmacists and physicians. [ Time Frame: in hospital ] [ Designated as safety issue: No ]
|Study Start Date:||February 2006|
|Study Completion Date:||July 2007|
The overall goal of the COLLABORATE study is to improve processes of care and patient outcomes by optimizing drug therapy via a hospital pharmacy practice model that integrates clinical pharmacists into the patient care team.
The intervention consists of a clinical pharmacist assigned to the patient care team for the purpose of providing proactive clinical pharmacy services. The study pharmacist will be available during normal office hours 5 days per week to provide clarification of the patient's medication history, identify and resolve actual and potential patient specific drug related problems/issues, participate in patient care rounds, provide drug information to the patient care team, provide patient education and discharge medication counselling, and provide physician and/or nursing staff education. The anticipated pharmacist to patient ratio is approximately 1:20.
Control patients will receive usual care. Usual care consists of reactive clinical pharmacy services (i.e. drug related issues identified as orders are received, or by patient profile review) provided by a ward based, not team based, clinical pharmacist.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00351676
|University of Alberta Hospital|
|Edmonton, Alberta, Canada, T6G 2B7|
|Royal Alexandra Hospital|
|Edmonton, Alberta, Canada, T5H 3V9|
|Grey Nuns Community Hospital|
|Edmonton, Alberta, Canada, T6L 5X8|
|Principal Investigator:||Ross T. Tsuyuki, PharmD, MSc||University of Alberta|